Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Concert Pharmaceuticals Inc patents


Recent patent applications related to Concert Pharmaceuticals Inc. Concert Pharmaceuticals Inc is listed as an Agent/Assignee. Note: Concert Pharmaceuticals Inc may have other listings under different names/spellings. We're not affiliated with Concert Pharmaceuticals Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "C" | Concert Pharmaceuticals Inc-related inventors


4-hydroxybutyric acid analogs

This invention relates to novel derivatives of 4-hydroxybutyric acid and prodrugs thereof, and pharmaceutically acceptable salts of the foregoing. This invention also provides pharmaceutical compositions comprising a compound of this invention and the use of such compositions in methods of treating narcolepsy, fibromyalgia, other disorders or conditions that are beneficially treated by improving nocturnal sleep or by administering sodium oxybate.. ... Concert Pharmaceuticals Inc

Inhibitors of the enzyme udp-glucose: n-acyl-sphingosine glucosyltransferase

This invention relates to novel inhibitors of udp-glucose: n-acyl-sphingosine glucosyltransferase and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering inhibitors of udp-glucose: n-acyl-sphingosine glucosyltransferase.. ... Concert Pharmaceuticals Inc

Deuterated emricasan

. . This invention relates to novel 3-amido-4-oxo-5-phenoxypentanoic acids, and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a caspase protease inhibitor.. ... Concert Pharmaceuticals Inc

Deuterated tic10

This invention relates to novel imidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(1h)-one compounds, and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions alone or in combination with other therapeutics in the treatment of diseases and conditions that are beneficially treated by administering an inducer of the gene encoding tumor necrosis factor (tnf) related apoptosis-inducing ligand (trail) superfamily member 10.. ... Concert Pharmaceuticals Inc

Pyrimidine phosphonic acid esters

This invention relates to compounds of formula (a), and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a viral dna polymerase inhibitor.. ... Concert Pharmaceuticals Inc

Morphinan compounds

This invention relates to novel morphinan compounds and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a σ1 receptor agonist that also has nmda antagonist activity.. ... Concert Pharmaceuticals Inc

Methods of treating hyperglycemia

. . . . The present invention relates to a novel method of treating hyperglycemia in a patient with poor glycemic control. The method comprises administering to the patient an effective amount of a compound described herein.. ... Concert Pharmaceuticals Inc

Morphinan compounds

. . . . This disclosure relates to novel morphinan compounds and their derivatives, pharmaceutically acceptable salts, solvates, and hydrates thereof. This disclosure also provides compositions comprising a compound of this disclosure and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a σ1 receptor agonist that also has nmda antagonist activity.. ... Concert Pharmaceuticals Inc

Substituted xanthine derivatives

This invention relates to novel compounds that are substituted xanthine derivatives and pharmaceutically acceptable salts thereof. For example, this invention relates to novel substituted xanthine derivatives that are derivatives of pentoxifylline. ... Concert Pharmaceuticals Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Concert Pharmaceuticals Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Concert Pharmaceuticals Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###